Skip to Content
Search Menu

SABCS | San Antonio Breast Cancer Symposium

SABCS 2023

Hatem Azim

Using Fertility Options May be Safe for Patients with HR-positive Breast Cancer

/ Hatem Azim
Breast cancerSABCS23 Play the Video

Oncology / Hematology • No. 15 • 2023

  • 2023
Get access

SABCS 2023: HR-Positive Breast Cancer Patients May Safely Use Fertility Options

/ BestPractice Nordic
Breast cancerSABCS23

SABCS 2023: Younger Postmenopausal Women May Safely Skip Adjuvant Radiotherapy

/ BestPractice Nordic
Breast cancerSABCS23

SABCS 2023: Neoadjuvant Chemotherapy: May Reduce Regional Nodal Irradiation in Breast Cancer Patients

/ BestPractice Nordic
Breast cancerSABCS23

SABCS 2023: Blood Hormone Levels: A Key to Effective Breast Cancer Prevention in Post-Menopausal Women

/ BestPractice Nordic
Breast cancerSABCS23

BestPractice Nordic is covering SABCS 2023

/ BestPractice Nordic
Breast cancerSABCS23

SABCS 2022

Elsebeth Lynge

Does breast density affect the risk of breast cancer?

/ Elsebeth Lynge
Breast cancerSABCS22 Play the Video

Type 2 diabetes and breast cancer surgery – increased risk of postoperative complications

/ BestPractice Nordic
Breast cancerSABCS22TreatmentType 2-diabetes

Neoadjuvant Enhertu and HER2-low breast cancer – Overall response rate of 75%

/ BestPractice Nordic
Breast cancerSABCS22Treatment

Trodelvy (sacituzumab govitecan) – A new effective treatment option for breast cancer

/ BestPractice Nordic
Breast cancerSABCS22Treatment

Interruption of endocrine therapy for pregnancy – New promising data presented at SABCS22

/ BestPractice Nordic
Breast cancerSABCS22

SABCS 2022 – From basic science breakthroughs to practice-changing new therapies

/ BestPractice Nordic
Breast cancerSABCS22

SABCS 2020

SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer

/ Shanu Modi
Breast cancerSABCS20 Play the Video

Robust survival outcome in HER2 positive metastatic breast cancer

/ Shanu Modi
Breast cancerSABCS20 Play the Video

Order the BestPractice Nordic magazine directly to your address for free.

Register and update your profile here.

Sign up

Onkologia / Hematologia • Nr. 4 • 2020

  • Eturauhassyöpä
  • Syövästä selviytyminen
  • Multippeli myeloma
Get access

SABCS2020 abstraktit

SABCS20: Circulating tumor cells can predict response in metastatic breast cancer

/ BestPractice Nordic
Breast cancerSABCS20

SABCS20: Trastuzumab deruxtecan is a promising new treatment for HER2 positive metastatic breast cancer

/ BestPractice Nordic
Breast cancerSABCS20

SABCS20: Abemacitib continues to show promising results in early breast cancer

/ BestPractice Nordic
Breast cancerSABCS20

SABCS20: Positive results of pembrolizumab in 1L for triple negative breast cancer regardless of chemotherapy partner

/ BestPractice Nordic
Breast cancerSABCS20

SABCS20: Postmenopausal women with early breast cancer and low risk score could skip adjuvant chemotherapy

/ BestPractice Nordic
Breast cancerSABCS20

Back to top